Nektar upgraded at Oppenheimer on upcoming mid-stage trial readout
Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Nektar upgraded to Outperform at Oppenheimer ahead of rezpeg readout in June
Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s ...
Yahoo Finance25d
Oppenheimer upgrades BioMarin on long term outlook
Oppenheimer upgrades BioMarin on long term outlook Amgen India opens with $200 million investment plan through 2025 National Grid sells $1.7 billion US renewables arm to Brookfield ...
Jewish Telegraphic Agency7d
The Jewish story behind ‘Oppenheimer,’ explained
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Oppenheimer downgrades bank stocks
Investing.com -- Oppenheimer has downgraded several bank stocks, including Cohen & Company, Goldman Sachs, and Jefferies, to Perform in a note Wednesday due to concerns about a delayed or canceled ...
Yahoo Finance1mon
IBM stock: Oppenheimer's deeper look at its valuation
Investing.com -- Oppenheimer analysts recently engaged with investors to discuss their outlook on IBM (NYSE:IBM), addressing key questions about software growth, consulting revenue, and valuation ...
Oppenheimer starts Cloudflare at outperform, Fastly at perform
Investing.com -- Oppenheimer analysts initiated coverage on Cloudflare (NYSE: NET) with an Outperform rating and Fastly (NYSE: FSLY) with a Perform rating in separate notes Thursday. Cloudflare was ...